Presbyterian now offering monoclonal antibody therapies for COVID patients

Coronavirus New Mexico

ALBUQUERQUE, N.M. (KRQE) – Presbyterian is now offering monoclonal antibody therapy for COVID-19 patients. The treatment is only available for those ages 12 and older who are at high risk of COVID hospitalization.


Story continues below


Treatment should be started within 10 days of symptoms and a positive COVID test. A full list of requirements to receive the treatment is available online.

Copyright 2022 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Latest Video

Now Trending on KRQE.com

New Mexico Hourly Forecasts ⟶

Albuquerque Hourly Forecast

Don't Miss

MORE IN DON'T MISS

Photo Galleries

MORE PHOTO GALLERIES

News Resources - Maps

MORE NEWS RESOURCES